Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 29 Pain, Postoperative 10 Colorectal Neoplasms 10 Neoplasms 8 Brain Neoplasms 8 Stomach Neoplasms 7 Prostatic Neoplasms 6 Lung Neoplasms 6 Pancreatic Neoplasms 5 Melanoma 5 Ovarian Neoplasms 4 Hemorrhage 4 Head and Neck Neoplasms 4 Agnosia 4 Rectal Neoplasms 3 Neurotoxicity Syndromes 3 Nasopharyngeal Carcinoma 3 Myoma 3 Multiple Endocrine Neoplasia Type 1 3 Meningioma 3 Lymphoma, Non-Hodgkin 3 Leiomyoma 3 Glioblastoma 3 Delirium 3 Colonic Neoplasms 3 Chronic Pain 3 Warts 2 Uterine Cervical Neoplasms 2 Stomatitis 2 Skin Neoplasms 2

Interventions

Etanercept 12 Adalimumab 12 Infliximab 7 golimumab 4 Tumor Necrosis Factor Inhibitors 4 Certolizumab Pegol 4 Abatacept 4 tofacitinib 2 tocilizumab 2 Rituximab 2 Antirheumatic Agents 2 Vitamin D 1 Vaccines 1 Syringes 1 Surveys and Questionnaires 1 Standard of Care 1 Sodium Chloride 1 Saline Solution 1 Radioimmunodetection 1 Prednisone 1 Practice Guidelines as Topic 1 Phlebotomy 1 Observation 1 Nivolumab 1 Methotrexate 1 Methods 1 Lysine Acetyltransferase 5 1 Licensure 1 Leflunomide 1 Interviews as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Arthritis, Rheumatoid × Sodium Chloride × Clear all

NCT05090124 2025-01-14

REALISE

NHS Greater Glasgow and Clyde

Phase NA Completed

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡